Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation? ; volume:18 ; number:1 ; day:24 ; month:8 ; year:2020 ; pages:1-5 ; date:12.2020
Thrombosis journal ; 18, Heft 1 (24.8.2020), 1-5, 12.2020
- Urheber
-
Giffard-Quillon, Lorine
Desmurs-Clavel, Helene
Grange, Claire
Jourdy, Yohann
Dargaud, Yesim
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-020-00228-9
- URN
-
urn:nbn:de:101:1-2020091021555627784844
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Giffard-Quillon, Lorine
- Desmurs-Clavel, Helene
- Grange, Claire
- Jourdy, Yohann
- Dargaud, Yesim
- SpringerLink (Online service)
Ähnliche Objekte (12)
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
Human Prothrombin/Phospholipids Interaction. Competitive Effect of an Anticoagulant Venom Phospholipase A2
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
Human Prothrombin/Phospholipids Interaction. Competitive Effect of an Anticoagulant Venom Phospholipase A2
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Activated Prothrombin Concentrates in Management of Bleeding in a Classical Hemophiliac with Inhibitor
Human Prothrombin/Phospholipids Interaction. Competitive Effect of an Anticoagulant Venom Phospholipase A2
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal